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Background: The single nucleotide polymorphism (SNP) rs7903146 (C/T), located in intron 4 of the transcription
factor 7-like 2 gene (TCF7L2), has been associated with an increased risk of developing Type 2 Diabetes, although
the molecular mechanism remain elusive. The TCF7L2 gene is alternatively spliced but an association between
genotype and splice variants has not been shown convincingly. We hypothesized that a yet unknown extra exon,
containing either the C or T genotype of the SNP rs7903146, could introduce a premature stop codon and consequently
result in nonsense-mediated decay (NMD).
Findings: Running the sequences C and T of the SNP region in different servers we found that the two alleles could
display differential recognition by splicing factors. The C variant showed the possible inclusion of an unknown exon. This
unknown exon contained a stop codon and thus could induce NMD. We then determined that the splicing pattern in
isolated mouse islets and MIN6 cells was similar to that in human pancreatic islets. Therefore, we used MIN6 cells to study
the splicing of human intron 4: two mini-genes of intron 4 containing either the C/C genotype or the T/T genotype were
transfected into MIN6 cells. Our constructs were spliced normally, excluding intron 4, but we did not observe the presence
of an extra exon with either construct.
Conclusions: We found that an extra exon could theoretically exist, although we were not able to capture it in our
model. A better model is needed to determine whether a theoretical extra exon can induce NMD.
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Grant et al. previously reported that the single nucleo-
tide polymorphism (SNP) rs7903146, consisting of a C
to T nucleotide change in intron 4 of the transcription
factor 7-like 2 gene (TCF7L2), was strongly associated
with the risk of developing type 2 diabetes (T2D) in
Icelandic, Danish, and USA populations (Grant et al.,
2006). Many other studies have confirmed these findings
in other populations (Helgason et al., 2007; Florez et al.,
2006; Lyssenko et al., 2007; Dahlgren et al., 2007), but
the mechanisms remain largely unknown. TCF7L2 and in-
sulin mRNA expression in human pancreatic islets was in-
creased in individuals carrying the at-risk T allele (Lyssenko
et al., 2007), however glucose-stimulated insulin secretion* Correspondence: nmn24@cornell.edu
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in any medium, provided the original work is pwas inversely associated, suggesting that TCF7L2 protein
might influence post-transcriptional events of insulin ex-
pression. Individuals with the T allele had an increased pro-
insulin to insulin ratio (Loos et al., 2007; Stolerman et al.,
2009). Proprotein Convertase 1 (PC1) is partly responsible
of this ratio since it cleaves proinsulin to obtain mature
insulin in the beta-cell. Therefore, these results suggest that
the SNP might modulate proinsulin processing in beta-cells
by modulating PC1 expression. Indeed, the promoter of
PC1 was shown to have theoretical TCF-binding sites
(Loos et al., 2007; Stolerman et al., 2009), thus TCF7L2 pro-
tein could modulate insulin processing, indirectly through
modulating PC1 expression. In vivo, the T allele predicted
hyperglycaemia which was associated to reduced insulin se-
cretion but not to reduced insulin sensitivity (Cauchi et al.,
2006; Wang et al., 2007), indicating that indeed the SNP af-
fects beta-cells and insulin production/secretion but does
not affect insulin resistance of peripheral tissues. The lattern Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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probably would have been increased, and which would have
indicated that it is the conversion of proinsulin to insulin
that is affected in individuals with the T allele.
TCF7L2 is encoded by 17 exons, five of which are al-
ternatively spliced (exons 4, 13, 14, 15, and 16) and show
tissue-specific expression in both humans (Mondal et al.,
2010) and mice (Weise et al., 2010). Since the SNP
rs7903146 is found in a non-coding region and several
unknown protein factors bind to the C allele but not the
T (Cauchi et al., 2008), we hypothesized that different
splicing factors could bind to the T allele, relative to
the C allele, and alter the splicing pattern of TCF7L2
mRNA. Indeed, transcripts retaining exons 14 and 15
were significantly correlated with rs7903146 (Prokunina-
Olsson et al., 2009; Mondal et al., 2010), however it is
not clear how a SNP in intron 4 could affect splicing of
exons 14 and 15. We hypothesized that a yet unknown
exon with a premature stop codon could be alternatively
spliced in beta-cells with the T genotype. A premature
stop codon in one of the genotypes could induce
nonsense-mediated decay (NMD), and thus result in dif-
ferent expression of total TCF7L2 mRNA in T carriers,
as seen in several studies (Pang et al., 2011; Lyssenko
et al., 2007). This could explain altered proinsulin process-
ing, since the promoter of PC1 has theoretical TCF-binding
sites (Loos et al., 2007).
Materials and methods
Isolation of mouse islets and culture of MIN6 cells was car-
ried out as previously described (Casas et al., 2008). MIN6
cells were transfected with lipofectamine (Invitrogen).
The study was approved by the Ethics Committee of
Clinical Research of the Hospital Clinic, Barcelona.
Splicing analysis
RNA from both, MIN6 cells and isolated mouse islets,
was extracted with the NucleoSpin® RNA kit (Macherey-
Nagel) and cDNA was synthesized with Superscript® III
Reverse Transcriptase (Invitrogen) according to manu-
facturer’s instructions. Alternative splicing was analyzed
by PCR: exon 4 splicing was determined using primers
designed for exons 3 and 5. Similarly, alternative splicing
at the 3′ end was determined with primers for exons 12
and 17. PCR products were run on an agarose gel, bands
were excised and cleaned with NucleoSpin® Gel and
PCR Clean-up kit (Macherey-Nagel). Bands were se-
quenced with the BigDye® Terminator v3.1 Cycle Se-
quencing kit (Applied Biosystems).
Constructs
DNA was amplified with Platinum® Taq DNA Polymer-
ase (Invitrogen) to make four segments of DNA. ex4:
segment containing exon 4 and part of the beginning ofintron 4; in4C: part of intron 4 containing the SNP with
the C/C genotype; in4T: part of intron 4 containing the
SNP with the T/T genotype; ex5: segment containing the
end of intron 4 and exon 5 (Figure 1, primers available
upon request). The in4C and in4T constructs were se-
quenced and differed only in the nucleotide intended.
All four constructs (ex4, in4C, in4T, ex5) were each ligated
with a pGEM®-T Vector System (Promega), transfected and
grown in Subcloning Efficiency™ DH5α™ Competent Cells
(Invitrogen). Clones were digested, cleaned, ligated,
transfected, and grown again in Competent Cells.
Plasmids containing ex4-in4C-ex5 or ex4-in4T-ex5
were obtained and the pGEM®-T vector was replaced
by a pcDNA3 vector.
Results
Characterization of alternative splicing in mouse islets
and MIN6 cells
Alternative splicing of Tcf7l2 was similar in isolated
mouse islets (Figure 2) and MIN6 cells (results not
shown). We determined that exons 4, 13, 14, 15 and 16
were alternatively spliced. PCR of exon 4 revealed two
bands, which after purification and sequencing, corre-
sponded to the inclusion (188 bp) and exclusion
(119 bp) of exon 4 (Figure 2A). Similarly, alternative
splicing in the 3′ region was examined using primers
in exons 12 and 17 and five bands were isolated. Three
major bands corresponded to 12–17 (exon 12 spliced
into exon 17) (88 bp), 12-15-17 (161 bp), and 12-13-17
(139 bp) and two minor bands corresponded to 12-15-
16-17 (189 bp) and 12-13-14-17 (210 bp) (Figure 2B).
In humans islets, Mondal et al. showed that the major
variant was 12–17, and the other variants present were
12-13-17, 12-15-17, 12-15-16-17 (Mondal et al., 2010).
Moreover, we found the same deletion of 12 nucleo-
tides in exon 7 and an insertion in exon 9, previously
described in other tissues (Duval et al., 2000). There-
fore, our results show that the splicing pattern in iso-
lated mouse islets and MIN6 cells is similar to that in
human islets, suggesting that MIN6 cells are a good
model in which to investigate alternative splicing of a
mini-gene containing human intron 4.
Theoretical determination of an extra exon inducing NMD
Splicing factors bind to exon splicing enhancer (ESE)
motifs to include an exon, or to exon splicing silencer
(ESS) motifs to exclude an exon. Running the two vari-
ant sequences of rs7903146 in the regulatory motif
search server developed by Gil Ast (http://astlab.tau.ac.il)
and a server developed in Roderic Guigó’s group, we found
that the two variants could display differential recognition
by splicing factors. The C variant could promote splicing,
due to the presence of an ESE motif, and thus cause exoni-
sation of a sequence creating a new exon inside intron 4,
Figure 1 Alternative splicing of intron 4 mini-gene containing the C/C or T/T genotype. A: human TCF7L2 gene, exons are represented by
vertical lines. Grey boxes represent the parts of the gene that have been cloned to create the mini-gene B: amplification of four DNA segments
(ex4: segment containing exon 4 and part of the beginning of intron 4; in4C: part of intron 4 containing the SNP with the C/C genotype; in4T:
part of intron 4 containing the SNP with the T/T genotype; ex5: segment containing the end of intron 4 and exon 5). C: Two pcDNA3 plasmids
were obtained with either the C/C (ex4-in4C-ex5) or the T/T (ex4-in4T-ex5) genotype. D: 72 h after MIN6 cells were transfected with plasmids,
RT-PCR and an agarose gel were run, n = 4 independent experiments.
Figure 2 Alternative splicing of Tcf7l2 mRNA in isolated mouse islets. Agarose gel from RT-PCR with primers in exons 3 and 5 (A), and
primers in exons 12 and 17 (B). B: both lanes are from a similar PCR product (two bands were necessary to obtain enough product for the low
intensity bands). Exon sequences and base pair lengths are shown for all the bands that were sequenced.
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an mRNA containing a premature stop codon (grey shadow
in Figure 3), which could possibly undergo NMD and lead
to reduced levels of mRNA. The T variant on the other
hand displays motifs that are not present in the C variant
which correlate with splicing repressive sequences when
present in exons, ESS (Figure 3 italics in variant T). Thus,
we hypothesized that the polymorphism rs7903146 could
generate the exclusion of a yet unknown small alternative
exon, Figure 3. This alternative exon would contain a stop
codon, which would then cause NMD of the short mRNAs
produced. Indeed, NMD, which is the rapid degradation of
short mRNAs, is difficult to observe because short mRNAs
are degraded rapidly before it is possible to extract them
from cells for analysis (McGlincy and Smith, 2008). Thus
the C variant contains ESE sequences and the T variant con-
tains ESS sequences, suggesting a possible extra exon in the
C variant and the skipping of this exon in the T variant. We
undertook to investigate the existence of this extra exon.
Alternative splicing of intron 4 mini-genes
In order to study the possibility of an extra exon in in-
tron 4 we needed to clone intron 4. Since human intron
4 is very long (80 kbp) and difficult to clone, we created
a shorter version of human intron 4 which included
three different segments of this intron: one 581 bp seg-
ment contained exon 4 and the beginning of intron 4
(ex4), then a 1000 bp segment consisted of intron 4 in-
cluding the C/C or T/T genotype in the middle (in4C or
in4T), and finally a 500 bp segment contained the end of
intron 4 and exon 5 (ex5) (Figure 1, grey boxes). We ob-
tained two constructs with either the C/C (ex4-in4C-
ex5) or the T/T (ex4-in4T-ex5) genotype (Figure 1C).
The two constructs were each inserted in a pcDNA3
Vector System and transfected in MIN6 cells (an empty
pcDNA3 Vector was used as control). The transfection
of these two constructs (C and T) in MIN6 cells should
undergo similar splicing as in humans, since we found
that TCF7L2 has the same spliced exons in humans and
in mice, thus we considered that the same splicing ma-
chinery for TCF7L2 should be present. We hypothesized
that the C construct would produce mRNAs containing
an additional spliced exon corresponding to the intro-
duction of the SNP region while the T construct wouldVariant C
Variant T
Figure 3 Sequence of part of intron 4 around the C/T SNP rs7903146
nucleotides of the SNP are shown in capital and bold. Possible stop codon
and 3′ (gt) splice sites for the hypothesized extra exon are double underlin
underlined in the C variant and possible ESS are in italic in the T variant.skip this exon. 72 h after transfection, RNA was ex-
tracted and RT-PCR was performed with primers spe-
cific to human exons 4 and 5. The PCR products were
tested, isolated, and sequenced. No amplification was
observed in control cells and cells transfected with either
the C/C or T/T construct showed similar amplification
bands at approximately 160 bp (Figure 1D). The se-
quence of both bands corresponded to the sequence of
exon4-exon5 (166 bp), indicating that the mRNA from
our constructs was correctly spliced (intron 4 was ab-
sent) but our hypothetical extra exon was not present in
cells transfected with the C variant.
Discussion
Human TCF7L2 mRNA is alternatively spliced in sev-
eral tissues, including pancreatic islets of Langerhans
(Prokunina-Olsson et al., 2009; Mondal et al., 2010).
Certain variants are tissue-specific, such as variants
containing exon 16 which so far have only been found
in islets or colon (Prokunina-Olsson et al., 2009).
Mouse Tcf7l2 mRNA also has an alternative splicing
pattern which is tissue-specific (Weise et al., 2010).
However, splicing in mouse beta-cells or isolated
mouse islets has never been determined. We show here
that not only is mouse Tcf7l2 mRNA alternatively
spliced in MIN6 and isolated mouse islets but that the
splicing pattern is similar to that in isolated human is-
lets. In humans islets, Mondal et al. showed that the
major variant was 12–17 (exon 12 spliced into exon
17), and other variants were 12-13-17, 12-15-17, 12-
15-16-17 (Mondal et al., 2010). In accordance, we
found that the major transcript is 12–17, followed by
12-15-17 and 12-13-17. Interestingly, we also detected
the presence of variant 12-15-16-17, which in mouse
has only been detected in brain and gut (Weise et al.,
2010). In humans, exon 16 was only detected in islets,
mainly the 12-15-16-17 variant (Mondal et al., 2010),
indicating that this conserved isoform might be rele-
vant in islet function.
When analyzing the sequences of the two SNP variants
(C/T), we found that they exhibited differential recognition
by splicing factors. The C variant could promote splicing
and create a new exon inside intron 4, while the T variant
could skip this exon. Several studies have investigated the. Both genotypes the C and the T variant are shown: the C and T
s which if inserted could mediate NMD are in grey, possible 5′ (ag)
ed (possible exon includes nucleotides from ag to gt), possible ESE are
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yet been identified. We hypothesized that the reason for
this lack of detection is that the inclusion of this new exon
in the C variant could lead to an mRNA with a premature
stop codon. This mRNA would undergo NMD and conse-
quently reduce mRNA levels. NMD is a process that is dif-
ficult to detect, as the mRNA is highly unstable and very
rapidly degraded. The T variant could result in skipping of
this exon, reducing NMD, and finally increasing TCF7L2
mRNA levels, as others have previously reported (Lyssenko
et al., 2007; Pang et al., 2011).
Intron 4 of human TCF7L2 is unusually long; there-
fore we created two mini-genes of this intron with either
the C/C or T/T genotype. Since the SNP rs7903146 is
thought to be associated to altered insulin processing
and secretion we chose to investigate its effect in beta-
cells. We opted for MIN6 cells for two reasons: firstly,
as shown here, they splice Tcf7l2 mRNA similarly to
human TCF7L2 and secondly they do not have the cor-
responding genomic region for human rs7903146 in the
Tcf7l2 gene. Transfecting our constructs into MIN6 cells
showed that, indeed, exon 4 spliced correctly into exon
5, but the existence of an extra exon within intron 4 was
not detected. However, it is important to consider that,
by excluding the majority of the intron (78,000 bp), we
might have eliminated important information, and the
existence of an extra exon could still be likely. Another
approach will be to inhibit NMD in human beta-cells, to
better address the existence of this exon.
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